We are investigating a new treatment called KQB198 for individuals with advanced hematologic malignancies. The study aims to assess its safety and effectiveness, both alone and with other therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced Hematological Malignancies are cancers that affect the blood, bone marrow, and lymphatic system, leading to serious health issues. Common types include leukemia, lymphoma, and myeloma, which can cause symptoms like fatigue, frequent infections, and easy bruising.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
